Identifying risk factors for heart problems in COVID-19 patients
Official title: A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events
Funded at Beth Israel Deaconess Medical Center · NIH-10819470 · Data updated 2026-11-12
This study is looking at what makes some people more likely to have heart problems after being hospitalized with COVID-19, so we can better understand their needs and improve their care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | April 1, 2021 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $439,554 |
| NIH project number | 5R01HL157530-04 |
| Project ID | NIH-10819470 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 21 and older who have been hospitalized with confirmed COVID-19.
✕Less likely to help
Patients who have not been hospitalized with COVID-19 or are under 21 years old may not benefit from this research.
What this research studies
This research investigates the risk factors that contribute to cardiovascular events in patients hospitalized with COVID-19. By linking data from a national registry with health care claims and socioeconomic information, the study aims to identify which patients are most at risk and how these events impact their health outcomes. The approach includes analyzing biological markers and clinical histories to better understand the connections between COVID-19 and heart-related issues. This comprehensive data resource will help inform personalized patient care and guide future treatment strategies.
Why it matters
Potential benefit: If successful, this research could lead to improved identification and management of patients at risk for cardiovascular complications related to COVID-19.
How similar studies have gone: Other research has shown success in identifying risk factors for cardiovascular events in various populations, suggesting that this approach could yield valuable insights.
Where this research is happening
-
Beth Israel Deaconess Medical Center
Boston, United States Active
Researchers
- Principal investigator: Yeh, Robert — Beth Israel Deaconess Medical Center
- Study coordinator: Yeh, Robert
Related research
Other NIH-funded projects on the same topics.
-
Blocking a blood-vessel protein to protect the brain after COVID-19
Researchers are testing whether a drug that blocks the alpha5beta1 integrin can protect the brain and reduce memory and thinking problems after COVID-19 or in people with vascular dementia.
-
Investigating how COVID-19 affects people with sickle cell disease
This study is looking at how COVID-19 affects people with sickle cell disease, especially among African Americans, to better understand the risks and long-term symptoms they might face.
-
Investigating how the respiratory microbiome affects COVID-19 severity in older adults
This study is looking at how the germs in our lungs might affect how seriously older adults get sick from COVID-19, by checking samples from over 200 hospitalized patients to see if certain germs are linked to worse outcomes, especially for those with other health issues.
-
Exploring how COVID-19 affects children's reading skills
This study looks at how the COVID-19 pandemic has affected kids' reading skills, especially those between 0 and 11 years old, to find out which children might need extra help with their learning.
-
Identifying risk factors for severe COVID-19-related inflammatory syndrome in children
This study is looking at what makes some kids more likely to get sick with Multisystem Inflammatory Syndrome after having COVID-19, so we can find ways to help those who might need extra care.
-
Exploring how a specific protein affects cognitive issues related to COVID-19 in older adults
This study is looking at how COVID-19 might lead to memory and thinking problems in older adults with vascular dementia, and it will test if a special treatment can help improve their brain function by blocking a specific protein.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.